VVUS: VIVUS INC. (NASDAQ) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: D Edwards who wrote (3666)	12/15/1997 12:46:00 AM
From: Steve Childs	Read Replies (1) of 23519

The point I was trying to make was that as soon as Macrochem or Nexmed's topical applications become available Muse is going to be in big time trouble. If you don't think so then you must feel more comfotable about putting a supository down your urethra than merely rubbing a topical ointment on top of the glans of the penis. I could be wrong, but I suspect that most of my patients would agree with me. Again, these are my views. I think a pill is the easiest delivery system. If it works anywhere near reported then I believe it will be the biggest player in the ED market. That is the main point. From Hilm2, Motley fool board, provided by D Edwards. To the urologists on this thread: could the above statement really be from a urologist worth his salt talking? If so, hand me his license. He believes a topical ointment can do what a trans-urethral drug can do delivered directly into the local tissue affected? Or even Viagra, a systemic solution? Is this guy for real?

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next